共 50 条
- [21] Faster-acting insulin Fiasp versus insulin Novorapid in type 1 diabetes children and adolescents with sensor-augmented pump therapy [J]. HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 182 - 182
- [29] Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type I diabetes in the Netherlands [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 73 - 82